Sofosbuvir as Repurposed Antiviral Drug Against COVID-19: Why Were We Convinced to Evaluate the Drug in a Registered/Approved Clinical Trial?
Babak Sayad, Mahsa Sobhani, Reza Khodarahmi
Topics & Concepts
SofosbuvirMedicineVirologyClinical trialPharmacologyDrugRegimenHepatitis C virusCoronavirus disease 2019 (COVID-19)PandemicIntensive care medicineInternal medicineVirusRibavirinInfectious disease (medical specialty)DiseaseHepatitis C virus researchMosquito-borne diseases and controlDrug-Induced Hepatotoxicity and Protection